Priority setting for health interventions in Mexico's System of Social Protection in Health

González-Pier, Eduardo; Gutiérrez-Delgado, Cristina; Stevens, Gretchen A; Barraza-Lloréns, Mariana; Porras-Condey, Raúl; Carvalho, Natalie; Loncich, Kristen; Dias, Rodrigo H; Kulkarni, Sanjeevani; Casey, Anna; Murakami, Yuki; Ezzati, Majid; Salomon, Joshua A.

doi:10.1016/s0140-6736(06)69567-6

Cited by 109 publications

(73 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Mexico has shown the benefits of a priority-setting, evidence-based approach in healthcare reform. 32 Data, methods and evidence on effectiveness and equity of health interventions are becoming available, but gaps persist between this evidence and the application of constrained public health budgets.…”

Section: Evidence-based Priority Settingmentioning

confidence: 99%

Recommendations to improve the National Development Plan for Health

et al. 2012

View full text Add to dashboard Cite

Section: Evidence-based Priority Settingmentioning

confidence: 99%

Recommendations to improve the National Development Plan for Health

et al. 2012

View full text Add to dashboard Cite

“…In spite of this, countries such as Brazil, Mexico, Chile and Argentina have an active policy of evaluating health technologies and it appears that this is the tendency in other countries in the region (Banta, 2009). In the process of prioritization and selection of health interventions, included in different packets (public health, community health programs of low and intermediate complexity, special health programs and those of high complexity), the disease frequency and evaluations of cost-benefit play a fundamental role (González-Pier, 2006). Chile has a mixed public-private health system, in that the public health insurance FONASA is financed on the basis of the social security and fiscal support which covers 70% of the population and a private health insurance system, the ISAPRES which covers a further 16% of the Chilean population (Health Ministry, Chile, 2009 (Glick, 1998;Sonneberg, 2002;Mohadevia, 2003), we found a substantial number (163/228 ) of those undergoing cancer screening to incur at least one false-positive result, in terms of a serum PSA >4.0ng/ml.…”

Section: Cost-analysismentioning

confidence: 99%

Future Aspects of Prostate Biopsy – The Use of Primary Circulating Prostate Cells to Select Patients for Prostate Biopsy: Evidence, Utility and Cost-Benefit

Murray¹,

Reyes²,

Orellana³

et al. 2011

Prostate Biopsy

View full text Add to dashboard Cite

“…Due to various reasons, such as demographic and epidemiological changes, increased awareness, education and training, new technologies, increasing of family income and consequently high demand for health services and inability of countries to increase health resources with the same speed, no country could provide all health costs. Therefore, these choices and decisions about the inclusion of services and drugs in the health insurance package and financing thereof, is inevitable and unavoidable (3).…”

Section: Introductionmentioning

confidence: 99%

Stakeholders Analysis of Health Insurance Benefit Package Policy in Iran

et al. 2017

View full text Add to dashboard Cite

Background: Formulation of cost efficiency of health insurance benefit package requires an evidence-based policy making, with efficient management of stakeholders, therefore, identifying the stakeholders and considering their characteristics and interests and also the position and power of the main actors involved in policies seems to be necessary. For this purpose, this study aimed at analyzing the stakeholders of health insurance benefit package in Iran to specify their position in the assessed policy. Methods: This was done on a qualitative basis during years 2015 and 2016. Data was collected from semi-structured interviews, document analysis, and participation in decision-making meetings of the Supreme Council of Health Insurance, to identify the stakeholders, and their power, situation, interests, opportunities, and challenges. The data was analyzed with the content analysis approach using the MAXQDA software. Results: Overall, 23 stakeholders were identified and categorized in 6 groups, including policy makers, service providers, payers, suppliers of medicines and equipment, service recipients, and others. Sixteen stakeholders were at the national level, 3 stakeholders of regional, and 4 stakeholders of local level, however most stakeholders were owned by the public sector. Furthermore, 78% of stakeholders supported the policies of health insurance benefit package, and 48% had moderate power. Stakeholders had different interests and various opportunities and challenges to health insurance benefit package. Conclusions: The findings show that multiple stakeholders directly and indirectly affect the formulation and implementation of HIBP policies. Meanwhile, the members of supreme council of health insurance, legally being authorized to apply for entry of service and drug into the HIBP, have the most important role in decision making related to HIBP. Establishment of a systematic approach, considering the role of all stakeholders and alignment of their interests leads to a positive outcome of the stakeholders' power and finally effective formulation and implementation of policies, and facilitates the ultimate goal of this policy, which promotes public health.

show abstract

Priority setting for health interventions in Mexico's System of Social Protection in Health

Cited by 109 publications

References 17 publications

Recommendations to improve the National Development Plan for Health

Recommendations to improve the National Development Plan for Health

Future Aspects of Prostate Biopsy – The Use of Primary Circulating Prostate Cells to Select Patients for Prostate Biopsy: Evidence, Utility and Cost-Benefit

Stakeholders Analysis of Health Insurance Benefit Package Policy in Iran

Contact Info

Product

Resources

About